1. Teo, P M, Ma, B B, Chan, A T. Radiotherapy for nasopharyngea carcinoma – transition from two-dimensional to three-dimensional methods. Radiother Oncol 2004; 73: 163–172.
2. Luo, W, Ye, L, Yu, Z, He, Z, Li, F, Liu, M. Effectiveness of three-dimensional conformal radiotherapy for treating early primary nasopharyngeal carcinoma. Am J Clin Oncol 2010; 33: 604–608.
3. Zhang, B, Mo, Z, Du, W, Wang, Y, Liu, L, Wei, Y. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. Oral Oncol 2015; 51: 1041–1046.
4. Lee, A W, Ng, WT, Hung, W M et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys 2009; 73: 1121–1128.
5. Kam, M K, Chau, R M, Suen, J, Choi, P H, Teo, P M. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003; 56: 145–157.
6. Peng, G, Wang, T, Yang, K Y et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 2012; 104: 286–293.
7. Porter, S R, Scully, C, Hegarty, A M. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 28–46.
8. Tribius, S, Bergelt, C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: Is there a worthwhile quality of life gain? Cancer Treat Rev 2011; 37: 511–519.
9. Zheng, Y, Han, F, Xiao, W et al. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy. Radiat Oncol 2015; 10: 17.
10. Wu, V W, Ying, M T, Kwong, D L. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma. Br J Radiol 2011; 84: 843–849.
11. Dirix, P, Nuyts, S, van den Bogaert, W. Radiation-induced xerostomia in patients with head and neck cancer. Cancer 2006; 107: 2525–2534.
12. Saarilahti, K, Kouri, M, Collan, J et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 2005; 74: 251–258.
13. Nutting, C M, Morden, J P, Harrington, K J et al. Parotid-sparing intensity modulated versus conventional radiotherpay in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127–136.
14. Zou, K H, Warfield, S K, Bharatha, A et al. Statistical validation of image segmentation quality based on a spatial overlap index. Acad Radiol 2004; 11: 178–189.
15. Cao, J, Luo, J, Xu, G et al. Probe into the clinical significance of target volume and change of the normal organs in image-guided radiotherapy for nasopharyngeal carcinoma. Chin J Radiat Oncol 2007; 16: 81–85.
16. Barker, J L Jr, Garden, A S, Ang, K K et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT linear accelerator system. Int J Radiat Oncol Biol Phys 2004; 59: 960–970.
17. Zhang, Y, Lin, C, Wu, J et al. A longitudinal evaluation of early anatomical changes of parotid gland in intensity modulated radiotherapy of nasopharyngeal carcinoma patients with parapharyngeal space involvement. J Med Radiat Sci 2017; 64: 188–194.
18. Radfar, L, Sirois, D A. Structural and functional injury in minipig salivary glands following fractional exposure to 70 Gy of ionizing radiation: An animal model for human radiation induced salivary gland injury. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 267–274.
19. Wang, Z H, Yan, C, Zhang, Z Y et al. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: A longitudinal study. Laryngoscope 2009; 119: 1966–1974.
20. Fung, W K, Wu, V W, Teo, P M. Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma. J Radiat Res 2014; 55: 293–304.
21. Barker, J L, Garden, A S, Ang, K K et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 2004; 59: 960–970.
22. Au, K H, Ngan, R K C, Ng, A W Y et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG1301 study). Oral Oncol 2018; 77: 16–21.
23. Yan, H, Cao, X, Wang, J. Application of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Oncol Lett 2017; 14: 7773–7776.
24. Deasy, J O, Moiseenko, V, Marks, L et al. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010; 76: S58–S63.
25. Hey, J, Setz, J, Gerlach, R et al. Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study. Radiat Oncol 2011; 6: 125.
26. Feng, J, van der Zwaag, M, Stokman, M A, van Os, R, Coppes, R P. Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation. Radiother Oncol 2009; 92: 466–471.
27. Teshima, K, Murakami, R, Tomitaka, E et al. Radiation-induced parotid gland changes in oral cancer patients: Correlation between parotid volume and saliva production. Jpn J Clin Oncol 2010; 40: 42–46.